Click here to go to the previous page
Standard of Care: Challenges for Sponsors, Sites, and Patients in Clinical Trial Budgets
Program Code:
372
Date:
Wednesday, June 27, 2012
Time:
3:30 PM to 5:00 PM
EST
CHAIR
:
With 13+ years of industry experience, Michelle held data management positions at GlaxoWellcome and AstraZeneca. As Senior Manager, Product Management, Michelle is responsible for Medidata Designer, an eClinical design solution that helps sponsors optimize protocol design and authoring processes.
|
PRESENTER
(S):
With 13+ years of industry experience, Michelle held data management positions at GlaxoWellcome and AstraZeneca. As Senior Manager, Product Management, Michelle is responsible for Medidata Designer, an eClinical design solution that helps sponsors optimize protocol design and authoring processes.
|
Kelly Willenberg, SYNERGISM, LLC, United States
Soo Bang, Celgene Corporation, United States
Description
A sponsor and site share methods for identifying standard of care, including case studies that express the real-world impact on sites and patients. A novel patient survey explores the public perception of free care in the context of clinical trials.
Learning Objectives:
Define federal/state laws on third-party payer coverage for subscribers in clinical trials
Analyze methods to identify standard of care costs, including case studies illustrating challenges third-party payer billing creates for sites and patients
Evaluate patient survey - "free" trials.